70.10.Z - Head office activities
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
64.92.Z - Other forms of credit granting
66.19.Z - Other activities supporting financial services, excluding insurance and pension funds
68.20.Z - Rental and management of own or leased real estate
70.2 - Business and management consultancy activities
96.09.Z - Individual service activities
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Assets | 0 | 166,5 | -∞ |
Gross profit (loss) | 0 | -3 | ∞ |
EBITDA | 0 | -0,1 | ∞ |
Net profit (loss) | 0 | -3 | ∞ |
Cash | 0 | 30,5 | -∞ |
Liabilities and provisions for liabilities | 0 | 169,5 | -∞ |
Net income from sale | 0 | 0,3 | -∞ |
Short time liabilities | 0 | 104,3 | -∞ |
Working assets | 0 | 31 | -∞ |
Equity capital | 0 | -3 | ∞ |
Operating profit (EBIT) | 0 | -0,1 | ∞ |
Depreciation | 0 | 0 | -∞ |
% | % | p.p. | |
Profitability of capital | 100,2 | ||
Equity capital to total assets | -1,8 | ||
Gross profit margin | -1082,2 | ||
EBITDA Margin | -19,4 | ||
Days | Days | Days | |
Short term commitment turnover cycle | 0 | 137 546 | 137 546 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane